Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H20N2O |
| Molecular Weight | 244.3321 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(NC=C2C[C@H]3CCCN3C)C=C1
InChI
InChIKey=MKEGUJPBCIXABO-GFCCVEGCSA-N
InChI=1S/C15H20N2O/c1-17-7-3-4-12(17)8-11-10-16-15-6-5-13(18-2)9-14(11)15/h5-6,9-10,12,16H,3-4,7-8H2,1-2H3/t12-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-5-MeO-MPMI
Created by
admin on Sat Dec 16 10:15:16 GMT 2023 , Edited by admin on Sat Dec 16 10:15:16 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5-MEO-MPMI
Created by
admin on Sat Dec 16 10:15:16 GMT 2023 , Edited by admin on Sat Dec 16 10:15:16 GMT 2023
|
PRIMARY | 5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992,[1] and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active. | ||
|
143321-57-7
Created by
admin on Sat Dec 16 10:15:16 GMT 2023 , Edited by admin on Sat Dec 16 10:15:16 GMT 2023
|
PRIMARY | |||
|
9881324
Created by
admin on Sat Dec 16 10:15:16 GMT 2023 , Edited by admin on Sat Dec 16 10:15:16 GMT 2023
|
PRIMARY | |||
|
N29TFW7VRV
Created by
admin on Sat Dec 16 10:15:16 GMT 2023 , Edited by admin on Sat Dec 16 10:15:16 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
